Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Ocular Surface Disease in Malaysian Glaucoma Patients

NCT04609345 is registered in ClinicalTrials.gov with Santen Pharma Malaysia Sdn Bhd as lead sponsor.

NCT NCT04609345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04609345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Ocular Surface Disease in Malaysian Glaucoma Patients
Lead sponsor
Santen Pharma Malaysia Sdn Bhd
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2020
Completion date
May 31, 2021
Enrollment
400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ocular hypertension, pigment dispersion glaucoma, primary angle-closure glaucoma, primary open-angle glaucoma, pseudoexfoliation glaucoma